GTG price jumps on Applera lawsuit news
Thursday, 16 September, 2004
The share price of Genetic Technologies (ASX: GTG) jumped 25 per cent today on heavy trading after the company announced that the judge in GTG's lawsuit against Applera had ruled largely in the company's favour during the Markman hearing, in which the court rules on the precise meanings of certain disputed technical terms within GTG's patent claims.
Out of 15 disputed terms, the court ruled in favour of GTG's definition in 13 cases, and for the remaining two terms, the court adopted a definition consistent with GTG's position.
At the time of writing, GTG's shares were trading at AUD$0.475, up from a previous close of $0.38.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
